Education
About Us
Working with TipRanks
Follow Us
US Neurosurgical Holdings (USNU)
:USNU
USNU Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.47 - $1.94
Previous CloseN/A
Volume1.00K
Average Volume (3M)N/A
Market Cap
$24.19M
Enterprise Value-$651.36K
Total Cash (Recent Filing)$3.70M
Total Debt (Recent Filing)$64.00K
Price to Earnings (P/E)―
Beta-0.54
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.13
Shares Outstanding21,409,924
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.70
Price to Sales (P/S)0.00
P/FCF Ratio-0.39
Enterprise Value/Market Cap-0.03
Enterprise Value/Revenue-8.14
Enterprise Value/Gross Profit1.66
Enterprise Value/Ebitda0.11
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
US Neurosurgical Holdings News
PremiumCompany Announcements
US Neurosurgical Holdings Delays Annual Report
PremiumCompany Announcements
US Neurosurgical Holdings Announces Executive Leadership ChangesOptions Prices
Currently, No data available
---
Ownership Overview
9.83% Insiders
―
Mutual Funds
― Other Institutional Investors
90.17% Public Companies and
Individual Investors
USNU FAQ
What was US Neurosurgical Holdings ’s price range in the past 12 months?
US Neurosurgical Holdings lowest stock price was $0.47 and its highest was $1.94 in the past 12 months.
What is US Neurosurgical Holdings ’s market cap?
US Neurosurgical Holdings ’s market cap is $24.19M.
When is US Neurosurgical Holdings ’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were US Neurosurgical Holdings ’s earnings last quarter?
US Neurosurgical Holdings released its earnings results on May 15, 2018. The company reported $0.01 earnings per share for the quarter, beating the consensus estimate of N/A by $0.01.
Is US Neurosurgical Holdings overvalued?
According to Wall Street analysts US Neurosurgical Holdings ’s price is currently Overvalued.
Does US Neurosurgical Holdings pay dividends?
US Neurosurgical Holdings does not currently pay dividends.
What is US Neurosurgical Holdings ’s EPS estimate?
US Neurosurgical Holdings ’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does US Neurosurgical Holdings have?
US Neurosurgical Holdings has 21,409,924 shares outstanding.
What happened to US Neurosurgical Holdings ’s price movement after its last earnings report?
US Neurosurgical Holdings reported an EPS of $0.01 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of US Neurosurgical Holdings ?
Currently, no hedge funds are holding shares in USNU
Company Description
US Neurosurgical Holdings
U.S. NeuroSurgical Holdings, Inc., through its subsidiaries, owns and operates stereotactic radiosurgery centers that utilize gamma knife technology. The gamma knife is a stereotactic radio surgical device used to treat brain tumors and other malformations of the brain without invasive surgery. U.S. NeuroSurgical Holdings, Inc. was founded in 1993 and is based in Rockville, Maryland.
American Shared Hospital Services
―
Concord Medical Services
―
Cryo-Cell International
―
Oncology Institute
―
P3 Health Partners
―